Skip to content

Intraventricular Infusion Port Implantation via Lumbar Puncture in the ManCancer pain

Intraventricular Infusion Port Implantation via Lumbar Puncture in the Management of Head and Facial Cancer-Related Pain: A Multicenter Prospective Randomized Controlled Study

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106745
Enrollment
Unknown
Registered
2025-07-29
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

Ventricle Group:Implantation of intraventricular infusion port through lumbar puncture
Spine Group:Spinal infusion port implantation

Sponsors

The First Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1 Males or females aged >= 18 years, diagnosed with cancer pain; 2 Pain involving the cranial nerves, namely head and facial pain; 3 Patients with moderate to severe pain that is unresponsive to conservative treatment, with a score of >= 5 on the Numerical Rating Scale (NRS-11); 4 Voluntary signing of the informed consent form.

Exclusion criteria

Exclusion criteria: 1 Patients in poor general condition and unable to undergo surgery; 2 Patients with a life expectancy of no more than three months; 3 Patients with coagulation disorders or at risk of infection; 4 Patients who refuse to participate in this trial; 5 Patients whose intellectual or psychological status does not support completion of the follow-up for this study and may confound the results of this study.

Design outcomes

Primary

MeasureTime frame
Efficacy rate;

Secondary

MeasureTime frame
Numerical Rating Scale for pain,NRS-11;Pain Catastrophizing Scale,PCS;Insomnia Severity Index ,ISI;intrathecal morphine daily dosage;survival period;oral medications;

Countries

China

Contacts

Public ContactDong Daosong

The First Hospital of China Medical University

dds_19861118@163.com+86 180 4009 7361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026